Reply to comment

Oct. 6, 2025, 12:28 a.m. -  side effects of cjc and ipamorelin
CJC 1295 and Ipamorelin are two of the most frequently discussed peptides in fitness, anti‑aging, and medical research circles today. They work together as a duo that stimulates growth hormone release from the pituitary gland, but they also come with a range of potential side effects that users should be mindful of. This guide aims to walk you through what these substances are, how they interact, why people use them, and which adverse reactions may arise during or after treatment. CJC 1295 Ipamorelin Side Effects: A Comprehensive Guide When considering any peptide therapy, the first step is to understand that each compound can affect the body in ways that extend beyond its primary purpose. For CJC 1295—a growth hormone releasing factor that has a half‑life of about 30 hours—and Ipamorelin—a selective ghrelin receptor agonist known for its minimal impact on cortisol and prolactin levels—common side effects often include feelings of fluid retention, numbness or tingling in the extremities, mild headaches, increased appetite, fatigue, and occasionally joint pain. These symptoms are usually transient and diminish as the body adapts to regular dosing. However, more serious reactions such as swelling of the face, hands, or feet, a persistent high blood pressure reading, severe sleep disturbances, or signs of an allergic reaction (rash, itching, difficulty breathing) should prompt immediate medical evaluation. Understanding CJC 1295 Ipamorelin CJC 1295 and Ipamorelin are not drugs in the traditional sense

Post your comment

Required for comment verification

Prayer Requests And Enquiries